Newsletters
The header image is the default header image for the site.EPICC Statewide Status Report
Print Article
POSTED: October 30th, 2020
POSTED IN: EM Pulse - The Official Newsletter of MOCEP, September/October 2020,
Missouri has adopted a “medication first” model which incentivizes rapid and sustained access to FDA-approved medicines to treat opioid use disorder, i.e. buprenorphine, methadone and naltrexone, as well as incorporating naloxone as a rescue medicine.
The Behavioral Health Network of Greater St. Louis, and the Missouri Hospital Association, in partnership with The Missouri Department of Mental Health, Missouri Institute of Mental Health, and many other state agencies, continue to identify and support Missouri communities disproportionately affected by opioid-related morbidity and mortality.